Sodium Phenylbutyrate IV Therapy for Cancer Treatment
What is Sodium Phenylbutyrate (SPB)?
Sodium phenylbutyrate (SPB) has shown its potential as an anticancer therapy in numerous cancer types. It leads to the apoptosis of cancer cells through the regulation of the surviving pathways. It also antagonizes the glutamine pathway which most cancer cells use aside from glucose to survive.
The mechanism involves the depletion of glutamine through the formation of phenylacetylglutamine. Sodium phenylbutyrate is FDA approved for the treatment of urea cycle disorders which removes ammonia from the bloodstream.
Benefits of Sodium Phenylbutyrate IV Therapy
Sodium Phenylbutyrate, Which Is Easier To Just Say (SPB) For Short, Has Shown To Have Harsh Effects Against Certain Types Of Cancer Cells. It Also Stops the Rapid Reproduction Of Unhealthy Cells. Furthermore, It Has been Shown To Induce Cancer Cell Death.
4-Phenylbutyrate inhibits histone deacetylase, resulting in cell cycle gene expression modulation, reduced cell proliferation, increased cell differentiation, and apoptosis. This agent also initiates fragmentation of genomic DNA, resulting in decreased DNA synthesis and the inhibition of tumor cell migration and invasion.
Sodium Phenylbutyrate is converted to a substance in the body that helps the kidneys eliminate waste substances from the body. This comes very handy when dealing with ammonia-producing bacteria and during bacterial die-off. Several bacterial toxins can destabilize cell membranes leading to dysfunctions in cell signaling and homeostasis as well as neurodegeneration.
Call (949) 581-HOPE (4673), email us at [email protected] , or chat with us live to schedule your appointment. We are here to answer any questions and to help you schedule a personal consultation with an Integrative Cancer Specialist.